BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33898930)

  • 1. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma.
    Ladetto M; Dreyling M
    Hemasphere; 2021 May; 5(5):e559. PubMed ID: 33898930
    [No Abstract]   [Full Text] [Related]  

  • 2. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma.
    Linton K; Dreyling M
    Hemasphere; 2020 Oct; 4(5):e464. PubMed ID: 32885149
    [No Abstract]   [Full Text] [Related]  

  • 3. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Rule S; Salles G; Vitolo U; Ladetto M;
    Ann Oncol; 2016 Sep; 27(suppl 5):v83-v90. PubMed ID: 27664263
    [No Abstract]   [Full Text] [Related]  

  • 4. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Rule S; Salles G; Vitolo U; Ladetto M;
    Ann Oncol; 2017 Dec; 28(12):3109. PubMed ID: 28327933
    [No Abstract]   [Full Text] [Related]  

  • 5. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Marcus R; Salles G; Vitolo U;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi59-63. PubMed ID: 21908506
    [No Abstract]   [Full Text] [Related]  

  • 6. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Ghielmini M; Marcus R; Salles G; Vitolo U; Ladetto M;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii76-82. PubMed ID: 25122695
    [No Abstract]   [Full Text] [Related]  

  • 7. EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas.
    Ladetto M; Dreyling M
    Hemasphere; 2020 Apr; 4(2):e351. PubMed ID: 32309788
    [No Abstract]   [Full Text] [Related]  

  • 8. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes.
    van de Loosdrecht AA; Mandac Smoljanović I
    Hemasphere; 2022 Mar; 6(3):e695. PubMed ID: 35233507
    [No Abstract]   [Full Text] [Related]  

  • 9. EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.
    Eichhorst B; Ghia P
    Hemasphere; 2021 Jan; 5(1):e520. PubMed ID: 33403356
    [No Abstract]   [Full Text] [Related]  

  • 10. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2009 May; 20 Suppl 4():119-20. PubMed ID: 19454429
    [No Abstract]   [Full Text] [Related]  

  • 11. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v181-3. PubMed ID: 20555076
    [No Abstract]   [Full Text] [Related]  

  • 12. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Dreyling M;
    Ann Oncol; 2008 May; 19 Suppl 2():ii77-8. PubMed ID: 18456778
    [No Abstract]   [Full Text] [Related]  

  • 13. EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic.
    Dreyling M; Aurer I; Federico M; Jerkeman M; Kersten MJ; Linton K; Mey U; Tilly H; Buske C
    Hemasphere; 2021 Feb; 5(2):e529. PubMed ID: 33880434
    [No Abstract]   [Full Text] [Related]  

  • 14. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Dreyling M; Geisler C; Hermine O; Kluin-Nelemans HC; Le Gouill S; Rule S; Shpilberg O; Walewski J; Ladetto M;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii83-92. PubMed ID: 25210087
    [No Abstract]   [Full Text] [Related]  

  • 15. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ledermann JA; Raja FA; Fotopoulou C; Gonzalez-Martin A; Colombo N; Sessa C;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv259. PubMed ID: 30285216
    [No Abstract]   [Full Text] [Related]  

  • 16. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.
    Hiddemann W;
    Ann Oncol; 2003 Aug; 14(8):1163-4. PubMed ID: 12881368
    [No Abstract]   [Full Text] [Related]  

  • 17. Newly diagnosed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Hiddemann W; Dreyling M
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii63-4. PubMed ID: 17491052
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
    Hemasphere; 2021 Apr; 5(4):e567. PubMed ID: 33824948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
    Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U
    Hemasphere; 2021 Feb; 5(2):e528. PubMed ID: 33554050
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
    Hemasphere; 2021 Dec; 5(12):e659. PubMed ID: 34859196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.